A 42-year-old woman comes to the clinic for a follow-up visit. Two weeks ago, she was eval… — USMLE Step 3

A $42$ -year-old woman comes to the clinic for a follow-up visit. Two weeks ago, she was evaluated for fatigue and was found to have a hemoglobin concentration of $9.8 \text{ g/dL}$ , a mean corpuscular volume of $74 \text{ fL}$ , and a serum ferritin level of $8 \text{ ng/mL}$ . At that time, she was diagnosed with iron deficiency anemia secondary to heavy menstrual bleeding and was instructed to start oral ferrous sulfate. Today, the patient reports that she has been taking the medication consistently. She still feels somewhat tired but denies shortness of breath, chest pain, or lightheadedness. Her vital signs are within normal limits. Laboratory results today show a hemoglobin concentration of $10.1 \text{ g/dL}$ and a reticulocyte count of $5.2\%$ (normal: $0.5\%-1.5\%$ ). Which of the following is the most appropriate next step in management?

A
Switch to an intravenous iron formulation
Continue current therapy and schedule a follow-up in 4 weeksAnswer
C
Prescribe oral omeprazole to prevent gastrointestinal irritation
D
Order a bone marrow aspiration and biopsy
E
Admit the patient for a packed red blood cell transfusion

Answer

Continue current therapy and schedule a follow-up in 4 weeks

Oral iron therapy induces a peak reticulocyte response within 1 to 2 weeks of initiation. However, hemoglobin levels rise much more slowly, typically increasing by

1

2 \text{ g/dL}

every 3 to 4 weeks, with full normalization taking 6 to 8 weeks. This patient exhibits a brisk reticulocytosis, confirming adequate medication adherence, intestinal absorption, and bone marrow responsiveness. Because her response aligns perfectly with the expected physiological timeline, the best next step is to continue the current regimen and reevaluate her hemoglobin levels in 4 weeks.

Step-by-Step Solution

Identify the patient's diagnosis and treatment timeline.

The patient has iron deficiency anemia and has been on oral ferrous sulfate for 2 weeks.

Establishing the duration of therapy is essential for interpreting follow-up laboratory parameters.

Interpret the current laboratory findings.

Hemoglobin is minimally increased from baseline (

9.8

10.1 \text{ g/dL}

), but the reticulocyte count is significantly elevated at

5.2\%

This combination of findings differentiates a failing treatment regimen from an effective one that simply requires more time.

Determine the expected physiologic timeline for hematologic recovery.

Reticulocytosis peaks at 1 to 2 weeks, while hemoglobin typically rises by

1

2 \text{ g/dL}

every 3 to 4 weeks.

Applying this timeline confirms that the patient's current laboratory profile represents a successful and expected response to therapy.

Formulate the management plan.

Continue the oral iron supplementation and reevaluate the hemoglobin level in 4 weeks.

Intervening prematurely due to isolated lab expectations disrupts standard-of-care management.

Key Concept

Physiological timeline of hematologic recovery in iron deficiency anemia treated with oral iron supplementation.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic